Your search returned 85 studies. (Get alerts for new studies):
- Study of Total Body Irradiation in Combination With Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation Followed By Cyclosporine and
Conditions: HIV Infections
1 Location available
- Chemotherapy Followed by Allogeneic Stem Cell Transplantation in Treating Children With Hematologic Cancer
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
1 Location available
- Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remissio
Conditions: Leukemia
20 Locations available
- Allogeneic Transplantation Using TL1 & ATG for Older Patients With Hematologic Malignancies
Conditions: Blood Cancer - Leukemia
1 Location available
- Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation
Conditions: Multiple Myeloma - Blood and Marrow Transplant (BMT)
1 Location available
- TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD
Conditions: Myeloproliferative Disorders - Blood Cancer - Myelodysplastic Syndromes
1 Location available
- Allogeneic Stem Cell Transplantation in Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus
1 Location available
- Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic Sclerosis
Conditions: Scleroderma
1 Location available
- Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy
Conditions: Kidney Cancer - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus
Conditions: Lupus Erythematosus, Systemic
1 Location available
- Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease
Conditions: Hodgkin's Disease
1 Location available
- Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Conditions: Myelodysplastic Syndrome - Leukemia
1 Location available
- Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation in Aplastic Anemia
Conditions: Aplastic Anemia
1 Location available
- Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma
Conditions: Lymphoma, Non-Hodgkin
1 Location available
- Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma
Conditions: Lymphoma - Bone Marrow Transplantation
1 Location available
- Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL
Conditions: Acute Lymphoblastic Leukemia - Acute Myelogenous Leukemia
1 Location available
- Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia
Conditions: Anemia, Aplastic
1 Location available
- Allogeneic Bone Marrow Transplantation From HLA Identical Related Donors for Patients With Hemoglobinopathies
Conditions: Sickle Cell Disease - Hemoglobin SC
2 Locations available
- Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia
Conditions: Aplastic Anemia
2 Locations available
- Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant
Conditions: Hodgkin's Disease - Non Hodgkin's Lymphoma - Myeloma - Leukemia - Myelodysplasia
1 Location available
- Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute GVHD in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell Tran
Conditions: Stem Cell Transplantation
1 Location available
- Dose Escalation Trial of WT1-Sensitized T Cells for Residual or Relapsed Leukemia After Allogeneic Hematopoietic Progenitor Cell Transplantation
Conditions: Leukemia - Myelodysplastic Syndrome
1 Location available
- Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Patients With Severe Systemic Sclerosis
Conditions: Systemic Scleroderma - Severe Systemic Sclerosis
2 Locations available
- A Study Using Tacrolimus, Sirolimus and Bortezomib as Acute Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Peripheral Blood Stem Cell (PBS
Conditions: Graft vs Host Disease - Peripheral Blood Stem Cell Transplantation - Transplantation, Homologous
1 Location available
- A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Autologous or Allogeneic Transplantation for AML, CML, ALL, MDS, an
Conditions: Acute Myelogenous Leukemia (AML) - Chronic Myelogenous Leukemia (CML) - Acute Lymphoblastic Leukemia (ALL) - Myelodysplastic Syndrome (MDS) - B Cell Malignancies
1 Location available
- Allogeneic Transplantation for Pediatric Leukemias With Unrelated Donors
Conditions: Leukemia
1 Location available
- T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
Conditions: Acute Myelogenous Leukemia - Lymphoid Leukemia - Chronic Myelogenous Leukemia - Malignant Lymphoma - Hodgkin's Disease - Chronic Lymphocytic Leukemia - Myeloproliferative Disorder - Anemia, Aplastic - Myelodysplastic Syndromes
1 Location available
- Allogeneic Hand Transplantation Composite Tissue Allotransplantation
Conditions: Upper Extremity Injuries - Amputation
1 Location available
- Recombinant Human Growth Hormone (RH-GH) For Accelerating Immune Reconstitution Post Unrelated Cord Blood Transplant
Conditions: Allogeneic Stem Cell Transplantation
1 Location available
- Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies
Conditions: Hematologic Malignancies
1 Location available
- Allogeneic Transplantation For Severe Osteopetrosis
Conditions: Severe Osteopetrosis
1 Location available
- The Financial Impact of Allogeneic Stem Cell Transplantation on Patient and Family
Conditions: Transplant
2 Locations available
- Autologous and Allogeneic Transplant for Relapsed Lymphoma
Conditions: Non-Hodgkin's Lymphoma - Hodgkins Disease
1 Location available
- Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies
Conditions: Stem Cell Transplantation - Leukemia - Lymphoma
1 Location available
- Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation
Conditions: Leukemia, Myeloid, Acute - Leukemia, Lymphoblastic, Acute - Leukemia, Myelocytic, Chronic
1 Location available
- Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Children With Relapsed or Refractory High-Risk NBL.
Conditions: Neuroblastoma
4 Locations available
- A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Prima
Conditions: Acute Myelogenous Leukemia - Myelodysplastic Syndrome
1 Location available
- Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma
Conditions: Mycoses - Sezary Syndrome - Lymphoma, T-Cell, Cutaneous - Bone Marrow Transplant Failure - Lymphoma, Non-Hodgkin - Cutaneous T-cell Lymphoma of Skin
1 Location available
- Ph II of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG
Conditions: Transplantation, Homologous - Transplantation, Autologous - Multiple Myeloma - Blood and Marrow Transplant (BMT)
1 Location available
- Submission of Stem Cell Transplant Data to CIBMTR and NMDP
Conditions: Autologous Stem Cell Transplantation - Allogeneic Stem Cell Transplantation - Solid Tumors - Blood Cancers
1 Location available
- Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies
Conditions: Leukemia - Lymphoma - Myeloma
1 Location available
- Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation From Matched Related Donors
Conditions: Hematopoietic Stem Cell Transplantation
1 Location available
- Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplantation
Conditions: Non-Hodgkin's Lymphoma - Hodgkin's Lymphoma - Multiple Myeloma
1 Location available
- Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantat
Conditions: Hodgkin's Lymphoma - Non-Hodgkin's Lymphoma - Chronic Lymphocytic Leukemias - Multiple Myeloma With Plasmacytoma
1 Location available
- Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Leukemia - Lymphoma - Allogeneic Haematopoietic Stem Cell Transplantation - Acute Lymphoblastic Leukemia
1 Location available
- Study of Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT) to Treat Hematologic Malignancies and Hematopoietic Failure S
Conditions: Hematologic Neoplasms - Multiple Myeloma - Anemia, Aplastic - Hemoglobinuria, Paroxysmal - Myelofibrosis
1 Location available
- Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases
Conditions: Bone Marrow Failure - Osteopetrosis - Fanconi Anemia - Severe Combined Immunodeficiency
1 Location available
- Granulocyte Colony-stimulating Factor (G-CSF) Plus or Minus AMD3100 for Engraftment Post Allogeneic Transplant
Conditions: Stem Cell Transplant Patients
1 Location available
- A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies
Conditions: Acute Leukemia - Acute Myeloid Leukemia - Acute Lymphoblastic Leukemia - Biphenotypic Leukemia - Pre-leukemic Syndromes - Monosomy 7 - Bone Marrow Clonal Malformations - Juvenile Myelomonocytic Leukemia - Myelodysplastic Syndromes - Chronic Myelogenous Le
1 Location available
- Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders
Conditions: Mucopolysaccharidosis - Hurler Syndrome - Hunter Syndrome - Maroteaux-Lamy Syndrome - Sly Syndrome - Alpha Mannosidosis - Fucosidosis - Aspartylglucosaminuria - Adrenoleukodystrophy (ALD) - Globoid Cell Leukodystrophy (GLD) - Krabbe Disease - Metachromati
1 Location available
- Haploidentical Allogeneic Transplant w/Post Transplant Infusion of Regulatory T-cells (BMT Protocol 204)
Conditions: Leukemia - Leukemia Chronic Myelogenous Leukemia (CML) - Blood and Marrow Transplant (BMT) - Myelodysplastic Syndromes (MDS) - Lymphomas: Non-Hodgkin
1 Location available
- A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation
Conditions: Acute Lymphoblastic Leukemia - Acute Myeloid Leukemia - Chronic Myeloid Leukemia - Myelodysplastic Syndrome - Non-Hodgkin's Lymphoma
1 Location available
- Reduced-Intensity Preparative Regimen for Allogeneic Stem Cell Transplantation in Patients With Severe Aplastic Anemia
Conditions: Severe Aplastic Anemia
1 Location available
- Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphoc
Conditions: Multiple Myeloma
1 Location available
- Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Mal
Conditions: Hematological Malignancies
1 Location available
- A Database Study for Hematopoietic Stem Cell Transplantation and Marrow Injuries
Conditions: Autologous Stem Cell Transplantation - Allogeneic Stem Cell Transplantation - Solid Tumors - Blood Cancers
1 Location available
- Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Sele
Conditions: Severe Aplastic Anemia - MDS (Myelodysplastic Syndrome)
1 Location available
- Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant
Conditions: Stem Cell Leukemia of Unclear Lineage - Graft Versus Host Disease
1 Location available
- Atorvastatin for the Prophylaxis of Acute Graft-versus-host Disease in Patients Undergoing Matched Sibling Allogeneic Transplantation
Conditions: Graft vs Host Disease
1 Location available
- Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Conditions: Graft vs Host Disease - Cutaneous Sclerosis - Bronchiolitis Obliterans
8 Locations available
- An Exploratory Study of the Characteristics of and Challenges for International Families Seeking Medical Care in the United States
Conditions: Cancer - Allogeneic Peripheral Blood Stem Cell Transplant - Bone Marrow Transplantation
1 Location available
- Nonmyeloablative Allogeneic Transplant
Conditions: Aplastic Anemia - Paroxysmal Nocturnal Hemoglobinuria - Acute Myelogenous Leukemia - Acute Lymphocytic Leukemia - Myelodysplastic Syndrome - Chronic Myelogenous Leukemia - Chronic Lymphocytic Leukemia - Hodgkin's Lymphoma - Non-Hodgkin's Lymphoma - Mantle
1 Location available
- Exercise and Stress Management Post Autologous and Allogeneic Transplant
Conditions: Physiological Stress
5 Locations available
- A Reduced Toxicity Allogeneic Unrelated Donor Stem Cell Transplantation (SCT) for Severe Sickle Cell Disease
Conditions: Sickle Cell Disease
1 Location available
- Donor Enhancement With Plerixafor Post Myeloablative Allogeneic Transplant
Conditions: Failure of Bone Marrow Graft
1 Location available
- Patient-donor Vaccination in the Context of Allogeneic Bone Marrow Transplant With Post-transplant Cyclophosphamide
Conditions: Transplant-Related Cancer
1 Location available
- A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation From Related or Matched Unrelated Donors in Pediat
Conditions: Leukemia - Lymphoma - Neuroblastoma - Sarcoma - Desmoplastic Small Round Cell Tumor
1 Location available
- Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Refractory Crohn's Disease
Conditions: Crohn's Disease
1 Location available
- Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndrome
1 Location available
- Pilot Study of Lupron to Improve Immune Function After Allogeneic Bone Marrow Transplantation
Conditions: Acute Lymphocytic Leukemia - Acute Myelogenous Leukemia - Myelodysplastic Syndrome RAEB 1
2 Locations available
- Post T-plant Infusion of Allogeneic Cytokine Induced Killer Cells as Consolidate Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders
Conditions: Neural Tube Defects - Anemia - Leukemia, Myeloid - Bone Marrow Transplant Failure - Myelodysplastic Syndromes (MDS) - Myeloproliferative Disorders
1 Location available
- Sorafenib Maintenance Therapy for Patients With AML After Allogeneic Stem Cell Transplant
Conditions: Acute Myeloid Leukemia
2 Locations available
- Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Conditions: Leukemia - Lymphoma - HIV
3 Locations available
- Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematologica
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Myeloid Leukemia in Remission - Adult Erythroleukemia (M6a) - Adult Nasal Type Extranodal NK/T-cell
1 Location available
- High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Ly
Conditions: Post-transplant Lymphoproliferative Disorder - Recurrent Adult Burkitt Lymphoma - Recurrent Adult Diffuse Large Cell Lymphoma - Recurrent Adult Diffuse Mixed Cell Lymphoma - Recurrent Adult Grade III Lymphomatoid Granulomatosis - Recurrent Adult Immunobla
1 Location available
- A Study of Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma Using a Conditioning Regimen of Fludarabine, Melphalan, and Bortezo
Conditions: Multiple Myeloma
1 Location available
- Allogeneic Stem Cell Transplantation for Advanced Neuroblastoma Using MHC Mismatched Related Donors
Conditions: Neuroblastoma
1 Location available
- Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Synd
Conditions: Disorder Related to Bone Marrow Transplantation - Leukemia - Transplantation Infection
1 Location available
- Decitabine and Vaccine Therapy for Patients With Relapsed AML Following Allogeneic Stem Cell Transplantation
Conditions: Acute Myelogenous Leukemia
1 Location available
- Pharmacokinetics-based Mycophenolate Mofetil Dosing for GVHD Prevention
Conditions: Allogeneic Blood and Marrow Transplantation (BMT) - Graft Versus Host Disease
1 Location available
- Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match
Conditions: Acute Myelogenous Leukemia - Acute Lymphocytic Leukemia - Chronic Lymphocytic Leukemia - Chronic Myelogenous Leukemia - Hodgkins Disease - Non-Hodgkins Lymphoma - Aplastic Anemia - Multiple Myeloma - Myelodysplastic Syndrome
1 Location available
- Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT)
Conditions: Leukemia - Lymphoma - Myeloma - Myeloproliferative Diseases
1 Location available
- Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning
Conditions: Leukemia - Acute Myeloid Leukemia - Acute Lymphocytic Leukemia - Chronic Myeloid Leukemia - Chronic Lymphocytic Leukemia - Myeloproliferative Diseases - Non-Hodgkins Lymphoma - Hodgkins Lymphoma - Multiple Myeloma - Myelodysplastic Syndrome
1 Location available
- CD19-specific Donor T Cells for B Cell Malignancies After Allogeneic Transplant
Conditions: Recurrent Adult Acute Lymphoblastic Leukemia - Recurrent Adult Diffuse Large Cell Lymphoma - Recurrent Grade 1 Follicular Lymphoma - Recurrent Grade 2 Follicular Lymphoma - Recurrent Mantle Cell Lymphoma - Recurrent Marginal Zone Lymphoma - Recurrent Smal
1 Location available
|